← Back to Patent Explorer
US3855406A Expired / Lapsed US ⏱️ 0.0 years remaining

Thiaxanthene derivatives useful for treating peptic ulcers

Assignee: Boots Co PLC
•
Filing: 1973-04-19
•
Granted: 1974-12-17
•
Expires: 1993-04-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract N-Hydroxy-N-9-thiaxanthenylurea, its esters and substituted derivatives thereof are useful in the treatment of peptic ulcer. Pharmaceutical compositions thereof and method of treating therewith also disclosed.

Inventors

  • 👤 S Adams
  • 👤 B Armitage
  • 👤 N Bristow
  • 👤 B Heathcote

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 15:23
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/38

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 21 words
A THERAPEUTIC COMPOSITION USEFUL FOR TREATING PEPTIC ULCERS WHICH COMPRISES AN EFFECTIVE ANTI-SECRETORY AMOUNT OF A THIAXANTHEN COMPOUND OF THE FORMULA
Claim 2
Dependent Claim 21 words
A THERAPEUTIC COMPOSITION USEFUL FOR TREATING PEPTIC ULCERS WHICH COMPRISES AN EFFECTIVE ANTI-SECRETORY AMOUNT OF A THIAXANTHEN COMPOUND OF THE FORMULA
Claim 3
Dependent Claim 13 words
The composition of claim 1 wherein Ro is hydRogen and R1 is hydroxy.
Claim 4
Dependent Claim 13 words
The composition of claim 1 wherein Ro is alkoxy and R1 is hydroxy.
Claim 5
Dependent Claim 13 words
The composition of claim 1 in the form of a tablet or capsule.
Claim 6
Dependent Claim 12 words
The composition of claim 4 wherein the said composition is enteric coated.
Claim 7
Dependent Claim 15 words
The composition of claim 4 wherein said composition contains 25-500 mg. of the thiaxanthen compound.
Claim 8
Dependent Claim 11 words
The composition of claim 1 in the form of a suppository.
Claim 9
Dependent Claim 11 words
The composition of claim 1 wherein said thiaxanthen compound is N-hydroxy-N-9-thiaxanthenylurea.
Claim 10
Dependent Claim 30 words
The composition of claim 1 in the form of an enteric coated tablet or capsule useful for treating peptic ulcer comprising 25-500 mg. of N-hydroxy-N-9-thiaxanthenylurea and a pharmaceutically acceptable excipient.
Claim 11
Independent Claim 29 words
A method of treating peptic ulcer which comprises administering to a patient in need of said treatment a therapeutically effective anti-secretory amount of a thiaxanthen compound of the formula
Claim 12
Independent Claim 29 words
A method of treating peptic ulcer which comprises administering to a patient in need of said treatment a therapeutically effective anti-secretory amount of a thiaxanthen compound of the formula
Claim 13
Dependent Claim 12 words
The method of claim 10 wherein said thiaxanthen compound is administered orally.
Claim 14
Dependent Claim 20 words
The method of claim 10 wherein said thiaxanthen compound is administered at a dosage rate of 0.025-2 grams per day.
Claim 15
Dependent Claim 11 words
The method of claim 10 wherein said thiaxanthen compound is N-hydroxy-N-9-thiaxanthenylurea.

References Cited (Backward Citations)

US3481930A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1977-12-16 1978-06-17 1978-12-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1981-12-16 1982-06-17 1982-12-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1985-12-16 1986-06-17 1986-12-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag